1. 佐々木結花他、喀血診療指針 2024 日本呼吸器内視鏡学会 https://www.jstage.jst.go.jp/article/jjsre/46/6/46_317/_article/-char/ja
2. 佐々木結花、結核, medicina.2024;61:504-507.
3. MORITA K, MORIWAKI T, HABE S, TANIGUCHI-IKEDA M, HASEGAWA T, MINATO Y, AOI T, MARUYAMA T.Molecular aggregation strategy for inhibiting DNase.JACS Au.2024,4,6,2262-2266,doi:10.1021/jacsau.4c00210.
4. ITO S,MUTO Y,MINATO Y.非結核性抗酸菌(NTM)感染症治療薬として再注目されるクロファジミンに関する基礎研究の最新知見.結核.2024,99,4,99-104
5. Crowder R, Kato-Maeda M, Schwem B, Dela Tonga A, Geocaniga-Gaviola DM, Lopez E, Valdez CL, Lim AR, Hunat N, Sedusta AG, Sacopon CA, Atienza GAM, Bulag E, Lim D, Bascuña J, Shah K, Basillio RP, Berger CA, Lopez MCDP, Sen S, Allender C, Folkerts M, Karaoz U, Brodie E, Mitarai S, Garfin AMC, Ama MC, Engelthaler DM, Cattamanchi A, Destura R. Impact of heteroresistance on treatment outcomes of people with drug-resistant TB. IJTLD Open. 2024 Oct 1;1(10):466-472. doi: 10.5588/ijtldopen.24.0343.
6. Kodama T, Chikamatsu K, Kamada K, Mizuno K, Morishige Y, Igarashi Y, Osugi A, Aono A, Murase Y, Okumura M, Yoshiyama T, Takaki A, Mitarai S. Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB. Int J Tuberc Lung Dis. 2024 Oct 1;28(10):476-481. doi: 10.5588/ijtld.24.0190.
7. Wang L, Lim DR, Phelan JE, Reyes LT, Palparan AG, Sanchez MGC, Asuncion LAA, Tujan MAA, Medado IAP, Daga CMA, Llames JS, Mitarai S, Murase Y, Morishige Y, Ang CF, Malabad JCM, Montoya JC, Hafalla JC, Campino S, Hibberd ML, Ama CG, Basilio RP, La Paz EMC, Clark TG. Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines. Sci Rep. 2024 Aug 23;14(1):19602. doi: 10.1038/s41598-024-70471-x.
8. Bahk K, Sung J, Seki M, Kim K, Kim J, Choi H, Whang J, Mitarai S. Pan-Lineage Mycobacterium tuberculosis Reference Genome for Enhanced Molecular Diagnosis. DNA Res. 2024 Aug 11:dsae023. doi: 10.1093/dnares/dsae023.
9. Akinaga A, Takahashi M, Yamazaki T, Chikamatsu K, Matsushita S, Hashimoto Y, Iyoda T, Saika T, Mitarai S. Development and preliminary evaluation toward a new tuberculosis treatment monitoring tool: the PATHFAST TB LAM Ag assay. J Clin Microbiol:e00629-24.https://doi.org/10.1128/jcm.00629-24
10. Osugi A, Tamaru A, Yoshiyama T, Iwamoto T, Mitarai S, Murase Y. Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease. Microbiol Spectr. 2024 Jul 2;12(7):e0428923. doi: 10.1128/spectrum.04289-23.